Navigation Links
Optimization and Scale-up of a Hydrodynamically Limited Anti-Solvent Crystallization Process: From Lab to Plant
Date:8/13/2009

This two part Optimization and Scale-up of a Hydrodynamically Limited Anti-Solvent Crystallization Process: From Lab to Plant webinar series is based on an award winning paper presented at the 16th International Process Development Conference. The webinar series focuses on a semi-quantitative method for the optimization and scale-up of hydrodynamically limited antisolvent crystallization process. This protocol combines in situ Process Analytical Technologies (PAT) with Computational Fluid Dynamics (CFD) to facilitate the production of a knowledge based scale-up strategy for this mixing limited crystallization process.

Columbia, MD (PRWEB) August 13, 2009 -- Part 1 of the Optimization and Scale-up of a Hydrodynamically Limited Anti-Solvent Crystallization Process webinar series takes place on September 24 and presents this optimization protocol. Certain attributes of turbulent mixing have been identified to greatly impact key crystallization characteristics, such as the metastable zone width (MSZW), primary and secondary nucleation events, growth and agglomeration rates. This section focuses on the use of Process Analytical Technology (PAT) and Computational Fluid Dynamics (CFD) in understanding these common industrial crystallization challenges and in turn facilitates the production of methods for the scale-up and scale-down of this process.

Part 2 of the Optimization and Scale-up of a Hydrodynamically Limited Anti-Solvent Crystallization Process webinar series, on October 1, takes the developed protocol to a scale-down and scale-up environment and demonstrates how crystal nucleation, growth and dimension can be maintained on scale. This approach highlights the necessity for a link to be forged between crystal size, form, kinetics, etc. and the attained mixed environment. In turn, a platform is produced to facilitate the right first time crystallization scale-up, tech transfers and scale-down assessments of this hydrodynamically limited process.

The webinar presenter, Mark Barrett, received his Ph.D. from University College Dublin (UCD) in Ireland, where he also studied Chemical Engineering. His thesis work focused on crystallization development and scale-up. Previously, Mark worked for Schering-Plough as a Process Development Engineer. Mark is now a Senior Research and Development Engineer at the Solid State Pharmaceutical Cluster (SSPC), based in Ireland.

###

Read the full story at http://www.prweb.com/releases/crystallization/PAT/prweb2740064.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Seambiotic USA and NASA Glenn Research Center Signed Agreement for Large Scale Microalgae Process Optimization
2. DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches
3. ETS Laboratories Offers New Process Optimization Tools to the Fuel Ethanol Industry
4. U.S. Hospital Sales Opportunities Maximized Through Functional Optimization
5. Caliper Life Sciences and DiscoveRx Collaborate to Offer Solutions for Cell-Based GPCR Profiling and Lead Optimization
6. Genencor Launches Accellerase(R) 1500, Next Step Toward Scale-Up of Cellulosic Ethanol
7. ThalesNano Flow Reactor Realizes Microwave Speed With Scale-up Ability
8. DuPont Applied BioSciences Selects MBI to Collaborate on Process Development and Scale-Up for New Bio-based Product
9. ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
10. Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited
11. CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Optimization and Scale-up of a Hydrodynamically Limited Anti-Solvent Crystallization Process: From Lab to Plant
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... Lawrence, MA (PRWEB) , ... June 23, 2016 ... ... the Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research ... test platform of microbial tests introduced last year,” stated Bob Salter, Vice President ...
Breaking Biology Technology:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
Breaking Biology News(10 mins):